A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

Annals of Neurology

Volumn 52, Issue 3, 2002, Pages 276-284

  Hernán, Miguel A ^a   Takkouche, Bahi ^b   Caamaño Isorna, Francisco ^b   Gestal Otero, Juan J ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; COFFEE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT;

CASE-CONTROL STUDIES; COFFEE; COHORT STUDIES; HUMANS; PARKINSON DISEASE; RISK FACTORS; SMOKING;

EID: 0036714747     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10277     Document Type: Article

References (63)

1. Cigarette smoking and protection from Parkinson's disease
2. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women
3. The "protective" influence of cigarette smoking on Alzheimer's and Parkinson's diseases. Quagmire or opportunity for neuroepidemiology?
4. Cigarette smoking and the incidence of Parkinson's disease in two prospective studies
5. An evaluation of old and new tests of heterogeneity in meta-analysis in epidemiologic research
6. HEpiMA: A software for the identification of heterogeneity in meta-analysis
7. A retrospective study of smoking in Parkinson's disease
8. Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: A survey and explanatory hypothesis
9. Smoking and Parkinson's disease
10. Twin study of Parkinson disease
11. Nicotine exposure and Parkinson's disease
12. Smoking and Parkinson's disease
13. New data on the genetics of Parkinson's disease
14. A case-control study on Parkinson's disease
15. A case-control study of twin pairs discordant for Parkinson's disease: A search for environmental risk factors
16. A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease
17. Environmental factors in the etiology of Parkinson's disease
18. Epidemiologic study of Parkinson's disease in Hong Kong
19. Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease
20. Incidence and risk factors of Parkinson's disease in the Netherlands
21. Smoking and Parkinson's disease
22. Parkinson's disease: A case-control study of occupational and environmental risk factors
23. The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients
24. A pilot study of occupational and environmental risk factors for Parkinson's disease
25. Smoking and Parkinson's disease: Differences according to age at disease onset
26. Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: A case-control study
27. Environmental antecedents of young-onset Parkinson's disease
28. Parkinson's disease: A test of the multifactorial etiologic hypothesis
29. A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China
30. Smoking and Parkinson's disease
31. Multifactorial etiology in idiopathic Parkinson's disease: A case-control study
32. Parkinson's disease and the environment in early life
33. Environmental and genetic risk factors in Parkinson's disease: A case-control study in southern Italy
34. Environmental risk factors and Parkinson's disease: A case-control study in Taiwan
35. Smoking and Parkinson's disease: A case-control study in Germany
36. Smoking and Parkinson's disease: An age-dependent risk effect?
37. The epidemiology of Parkinson's disease in an Australian population
38. A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna Region of Italy
39. Smoking and Parkinson's disease: A dose-response relationship
40. Nutritional and occupational factors influencing the risk of Parkinson's disease: A case-control study in southeastern Sweden
41. Environmental risk factors in Parkinson's disease
42. Genetics, drugs and environmental factors in Parkinson's disease: A case-control study
43. Environmental, medical, and family history risk factors for Parkinson's disease: A New England-based case-control study
44. Smoking, alcohol, and coffee consumption preceding Parkinson's disease
45. Parkinson's disease and environmental factors
46. Smoking habits in multiple system atrophy and progressive supranuclear palsy
47. Parkinson's disease, smoking, and family history
48. Risk factors for Parkinson's disease: The Leisure World Cohort Study
49. Risk factors of Parkinson's disease in Indian patients
50. A case-control study of Parkinson's disease in urban population of southern Israel
51. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease
52. Smoking, alcohol, and coffee consumption and the risk of PD: Results from the Rotterdam Study
53. Precursors and natural history of Parkinson's disease: The Framingham Study
54. Risk factors for Parkinson's disease: Case-control study in the province of Cáceres, Spain
55. Association of coffee and caffeine intake with the risk of Parkinson's disease
56. Caffeine intake and the risk of incident Parkinson's disease: The Framingham Study
57. Diet and Parkinson's disease. I. A possible role for the past intake of specific foods and food groups. Results from a self-administered food frequency questionnaire in a case-control study
58. Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease
59. Basic methods for sensitivity analyses of biases
60. Relationship between caffeine intake and Parkinson disease
61. Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke
62. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors
63. Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease